34
Views
1
CrossRef citations to date
0
Altmetric
Review

Therapeutic approaches to organ preservation injury

Pages 1489-1496 | Published online: 28 Oct 2005

Bibliography

  • COLLINS BH: Organ transplantation. Ann. Surg. (2003) 238:S72–S89.
  • MCLAREN AJ, FRIEND PJ: Trends in organ preservation. Transpl. Int. (2003) 16:701–708.
  • STOREY KB: Cold ischemic organ preservation: lessons from natural systems. J. Invest. Med. (2004) 52:315–322.
  • SOUTHARD JH, BELZER FO: Organ preservation. Annu. Rev. Med. (1995) 46:235–247.
  • MÜHLBACHER F, LANGER F, MITTERMAYER C: Preservation solutions for transplantation. Transpl. Proc. (1999) 31:2069–2070.
  • 'T HART NA, LEUVENINK HG, PLOEG RJ: New solutions in organ preservation. Transpl. Rev. (2002) 16:131–141.
  • NYDEGGER UE, CARREL T, LAUMONIER T et al.: New concepts in organ preservation. Transpl. Immunol. (2002) 9:215–225.
  • CHEN FS, NAKAMURA T, WADA H: Development of new organ preservation solutions in Kyoto University. Yonsei Med. J. (2004) 45:1107–1114.
  • SALAHUDEEN AK: Cold ischemic injury of transplanted kidneys: new insights from experimental studies. Am. J. Physiol Renal Physiol. (2004) 287:F181–F187.
  • REDDY S, GREENWOOD J, MANIAKIN SB et al.: Non-heart-beating donor porcine livers: the adverse effect of cooling. Liver Transpl. (2005) 11:35–38.
  • RAUEN U, DE GROOT H: Mammalian cell injury induced by hypothermia - the emerging role for reactive oxygen species. Biol. Chem. (2002) 383:477–488.
  • RIVARD AL, GALLEGOS RP, BIANCO R et al.: The basic science aspect of donor heart preservation: a review./ Am. Soc. Extra Corp. Tech. (2004) 36:269–274.
  • AL-QATTAN MM: Ischaemia-reperfusion injury. J. Hand Surg. (1998) 23B:570–573.
  • WILHELM MJ, PRATSCHKE J, LASKOWSKI I et al.: Ischemia and reperfusion injury. Transpl. Rev. (2003) 17:140–157.
  • LAND WG: The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation. Transplantation (2005) 79:505–514.
  • CUZZOCREA S, RILEY DP, CAPUTI AP et al.: Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischaemia/reperfitsion injury. Pharmacol Rev. (2001) 53:135–159.
  • BHAUMIK G, SRIVASTAVA KK, SELVAMURTHY Wet al.: The role of free radicals in cold injuries. Int. J. Biometeorol (1995) 38:171–175.
  • IRIE H, KATO T, IKEBE K et ed.: Antioxidant effect of MCI-186, a new free radical scavenger, on ischemia-reperfusion injury in a rat hindlimb amputation model. Surg . Res. (2003) 120:312–319.
  • ABET, UNNO M, TAKEUCHI H et al.: A new free radical scavenger, edaravone, ameliorates oxidative liver damage due to ischemia-reperfusion in vitro and in vivo. Gastrointest . Surg. (2004) 8:604–615.
  • ITO K, OZASA H, HORIKAWA S: Edaravone protects against lung injury induced by intestinal ischaemia/reperfitsion in rat. Free Rad. Biol. Med. (2004) 38:369–374.
  • GHISLENI G, PORCILINCULA LO, CIMAROSTI H et al.: Diphenyl diselenide protects rat hippocampal slices submitted to oxygen-glucose deprivation and diminishes inducible nitric oxide synthase immunocontent. Brain Res. (2003) 986:196–199.
  • TESKA V, KUNTSCHER V, HASMAN D et al.: Importance of selenium for the influence of ischemia-reperfusion syndrome after kidney transplantation from a non-heart beating donor in a pig model. Transpl. Proc. (2002) 34:3057–3059.
  • TESKA V, KUNTSCHER, V MOLAEK J et al.: Can ischemia-reperfusion syndrome in transplanted kidneys procured from non-heart beating donors be influenced by adding selenium into the reperfusion solution? An experimental study. Transpl. Proceed. (2003) 35:3125–3127.
  • HORWITZ LD: Bucillamine: a potent thiol donor with multiple clinical applications. Cardiovasc. Drug Rev. (2003) 21:77–90.
  • NAKAO A, NETO JS, KANNO S et al.:Protection against ischemia/reperfitsion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both. Am. J. TranspL (2005) 5:282–291.
  • KATORI M, BUSUTTIL RW, KUPIEC-WEGLINSKI JW: Heme oxygenase-1 system in organ transplantation. Mansp/. (2002) 74:905–912.
  • OTTERBEIN LE: Carbon monoxide: innovative anti-inflammatory properties of an age-old gas molecule. Antioxid. Redox Signal. (2002) 4:309–319.
  • TSUCHIHASHI S, FONDEVILA C, KUPIEC-WEGLINSKI JN(/: Heme oxygenase system in ischemia and reperfusion injury. Ann. TranspL (2004) 9:84–87.
  • VILLA RF, GORNI A: Pharmacology oflazaroids and brain energy metabolism: a review. PharmacoL Rev. (1997) 49:99–136.
  • KAVANAGH RJ, KAM PC: Lazaroids: efficacy and metabolism of action of the 21-aminosteroids in neuroprotection. Br. J. Anaesthesia (2001) 86:110–119.
  • GARVIN PJ, NIEHOFF ML, ROBINSON SM et al.: Renoprotective effects of the 21-aminosteroid U74389G in ischemia-reperfusion injury and cold storage preservation. Transplantation (1997) 63:194–201.
  • DUGUAY P, CHEN H, DALOZE P et al.: Cardioprotective effects of the lazaroid U74389G following cold preservation and transplantation of rat hearts. Transplantation (1996) 61:1023–1028.
  • SHERMAN IA, SAIBIL FG, JANOSSYTI: y-Hydroxybutyrate mediated protection of liver function after long-term hypothermic storage. Transplantation (1994) 57:8–11.
  • YAMASAKI N, OKA T, YAMAMOTO S et al.: Twenty-four hour preservation in y-hydroxybutyrate improves lung function in a canine single-lung allotransplantation. Transplantation (1999) 67:529–533.
  • BOYD AJ, SHERMAN LA, SAIBIL FG et al.: The protective effect of y-hydroxybutyrate in regional intestinal ischaemia in the hamster. Gastroenterology (1990) 99:860–862.
  • ZHONG Z, WHEELER WD, LI X et al.:L-glycine: a novel anti-inflammatory, immunomodulatory, and cytoprotective agent. Curr. Opin. Clin. Nutr. Metab. Care (2003) 6:229–240.
  • THURMAN RG, SCHEMMER P, ZHONG Z et al.: Kupffer cell-dependent reperfusion injury in liver transplantation: new clinically relevant use of glycine. Langenbecks Arch. Chir. SuppL Kongressbd (1998) 115:185–190.
  • WEINBERG JM, DAVIS JA, ABARZUA M et al.: Cytoprotective effects of glycine and glutathione against hypoxic injury to renal tubes. J. Clin. Invest. (1987) 80:1446–1454.
  • MANGINO MJ, MURPHY MK, GRABAU GG et al.: Protective effects of glycine during hypothermic renal ischemia-reperfusion injury. Am. J. PhysioL (1991) 261:F841–F848.
  • LEE, W-C, JENG, L-B, LIN PJ et al.: Nitric oxide donor improved endothelium-dependent relaxation of canine hepatic artery after preservation with UW solution. TranspL Proceed. (2000) 32:2306–2307.
  • BAXTER K, HOWDEN B, SAUNDER A et al.: Improved cardiac preservation by the addition of nitroglycerine to colloid-free University of Wisconsin solution (MUW). J. Heart Lung TranspL (1999) 18:769–774.
  • QUINTANAAB, LENZI HL, ALMAD LL et al.: Effect of S-nitrosoglutathione (GSNO) added to the University of Wisconsin solution (UW): functional response to cold preservation/reperfusion of rat liver. Ann. HepatoL (2002) 1:183–191.
  • MCANULTY JF, FOLEY JD, REID TW et al.: Suppression of cold ischemic injury in stored kidneys by the antimicrobial peptide bactenecin. Cryobiology (2004) 49:230–240.
  • HAUET T, GOUJON JM, BAUMERT H et al.: Polyethylene glycol reduces the inflammatory injury to cold ischemia/ reperfusion in autotransplanted pig kidneys. Kid. Int. (2002) 62:654–667.
  • MATSUMOTO S: Clinical application of perfluorocarbons for organ preservation. Artif Cells Blood Substit. ImmobiL BiotechnoL (2005) 33:75–82.
  • HANSEN TN, DAWSON PE, BROCKBANK KG: Effects of hypothermia upon endothelial cells: mechanisms and clinical importance. Cryobiology (1994) 31:101–106.
  • KEVELAITIS E, NYBORG NC, MENASCHÉ P: Coronary endothelial dysfunction of isolated hearts subjected to prolonged cold storage: patterns and contributing factors. Ann. Thorac. Surg (1997) 63:20–27.
  • LAUDE K, BEAUCHAMP P, THUILLEZ C et al.: Endothelial protective effects of preconditioning. Cardiovasc. Res. (2002) 55:466–473.
  • STOICA SC, GODDARD M, LARGE SR:The endothelium in clinical cardiac transplantation. Ann. Thorac. Surg. (2002) 73:1002–1008.
  • PAROLARI A. RUBINI P, CANNATA A et al.: Endothelial damage during myocardial preservation and storage. Ann. Thorac. Surg. (2002) 73:682–690.
  • KANG DH, KANG SW, JEONG HJ et ed.: Transplant graft vasculopathy: an emerging target for prevention and treatment of renal allograft dysfunction. Yonsei Med. J. (2004) 45:1053–1058.
  • RUEL M, KHAN TA, VOISINE P et al.:Vasomotor dysfunction after cardiac surgery. Eur. j Cardiothoracic Surg. (2004) 26:1002–1014.
  • REDONDO J, MANSO AM, PACHECO ME et al.: Hypothermic storage of coronary endothelial cells reduces nitric oxide synthase activity and expression. Cryobiology (2000) 41:292–300.
  • ZOU W, YANG Q, YIM AP et al.: Impaired endothelium-derived hyperpolarising factor-mediated relaxation in porcine pulmonary microarteries after cold storage with Euro-Collins and University of Wisconsin solutions. Cardiothorac. RanspL (2003) 126:208–215.
  • YANG Q, ZHANG R-Z, YIM AP et aL: Histidine-tryptophan-ketoglutarate solution maximally preserves endothelium-derived hyperpolarizing factor-mediated function during heart preservation: comparison with University of Wisconsin solution. J. Heart Lung. TranspL (2004) 23:352–359.
  • WILSON CH, STANSBY G, HAS WELL M et al.: Evaluation of eight preservation solutions for endothelial in situ preservation. Transplantation (2004) 78:1008–1013.
  • CHU Y, WU YC, CHOU YC et ell.: Endothelium-dependent relaxation of canine pulmonary artery after prolonged lung graft preservation in University of Wisconsin solution: role of L-arginine supplementation. J. Heart Lung TranspL (2004) 23:592–598.
  • MOHARA J, OSHIMA K, TSUTSUMI Het al.: FK409 ameliorates ischemia-reperfusion injuty following 12-hour cold preservation. J Heart Lung. TranspL (2000) 19:694–700.
  • COHEN MV BAINES CP, DOWNEY JM: Ischemic preconditioning: from adenosine receptor to KAT? channel. Ann. Rev. PhysioL (2000) 62:79–109.
  • KOSIERADZKI M: Mechanisms of ischemic preconditioning and its application in transplantation. Ann. Transpl. (2002) 7:12–20.
  • MURRY CE, JENNINGS RB, REIMER KA et al.: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation (1986) 74:1124–1136.
  • CLAVIEN PA, SELZNER M, RUDIGER HA et aL: A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann. Surg. (2003) 238:843–850.
  • COMPAGNON P, LINDELL S, AMETANI MS et aL: Ischemic preconditioning and liver tolerance to warm or cold ischemia: experimental studies in large animals. Transplantation (2005). 79:1393–1400.
  • DE JONG JW, DE JONGE R, KEIJZER Eet al.: The role of adenosine in preconditioning. PharmacoL Thera)). (2000) 87:141–149.
  • OBATA T: Adenosine production and its interaction with protection of ischemic and reperfusion injury of the myocardium. Life Sci. (2002) 71:2083–2103.
  • TUNE JD, GORMAN MW, FEIGL EO: Matching coronary blood flow to myocardial oxygen consumption. J. Appl. Physiol. (2004) 97:404–415.
  • MUBAGWA K, FLAMENG W: Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc. Res. (2001) 52:25–39.
  • MENTZER RM, RAHKO PS, MOLINA-VIAMONTE Vet al.: Safety, tolerance, and efficacy of adenosine as an additive to blood cardioplegia in humans during coronary artery bypass surgery. Am. Cardiol . (1997) 79:38–43.
  • SILVA PH, DILLON D, VAN WYLEN DG: Adenosine deaminase inhibition augments interstitial adenosine but does not attenuate myocardial infarction. Cardiovasc. Res. (1995) 29:616–623.
  • GALLAGHER KP, MCCLANAHAN TB, MARTIN BJ et al.: Does adenosine deaminase inhibition protect ischemic myocardium? Adv. Exp. Med. Biol. (1994) 370:291–294.
  • MCCLANAHAN TB, IGNASIAK DP, MARTIN BJ et aL: Effect of adenosine deaminase inhibition with pentostatin on myocardial stunning in dogs. Basic Res. Cardiol. (1995) 90:176–183.
  • ELFATTAH-ABD AS, JESSEN ME, LEKVEN J et aL: Differential cardioprotection with selective inhibitors of adenosine metabolism and transport: role of purine release in ischemic and reperfusion injury. MoL Cell Biochem. (1998) 180:179–191.
  • GRUBER HE: Acedesine: a preclinical overview. Adv. Exp. Med. Biol. (1994) 370:423–426.
  • GALINANES M, ZHAI X, BULLOUGH D et aL: Protection against injury during ischemia and reperfusion by acadesine derivatives GP-1-468 and GP-1-668. Studies in the transplanted rat heart. J. Thorac. Cardiovasc. Surg. (1995) 110:752–761.
  • PASUPATHY S, HOMER -VANNIASINKAM S: Ischaemic preconditioning protects against ischaemia/ reperfusion injury: Emerging concepts. Eur. J. Vasc. Endovasc. Surg. (2005) 29:106–115.
  • GALLAGHER KP, MCCLANAHAN TB, MARTIN BJ et al.: Does adenosine deaminase inhibition protect ischemic myocardium? Adv. Exp. Med. Biol. (1994) 370:291–294.
  • BAXTER GF: Role of adenosine in delayed preconditioning of myocardium. Cardiovasc. Res. (2002) 55:483–494.
  • GAO B, LI N, WANG Yet al.: Protective effect of L-arginine preconditioning on ischemia and reperfusion injury associated with rat small bowel transplantation. World J. Gastroenterol. (2005) 11:2994–2997.
  • KLONER RA, REZKALLA SH: Cardiac protection during acute myocardial infarction: Where do we stand in 2004? J. Am. Coll. Cardiol. (2004) 44:276–286.
  • SOUTHARD JH, VAN GULIK TM, AMETANI MS et aL: Important components of the UW solution. Transplantation (1990) 49:251–257.
  • OPIE LH, SACK MN: Metabolic plasticity and the promotion of cardiac protection in ischemia and ischemic preconditioning. J. Mol. Cell. Cardiol. (2002) 34:1077–1089.
  • NICOLINI F, BEGHI C, MUSCARI C et al.: Myocardial protection in adult cardiac surgery: current opinions and future challenges. Eur. j Cardiothoracic Surgery (2003) 24:986–993.
  • VIRAG L, SZABO C: The therapeutic potential of poly(ADP-ribose)polymerase inhibitors. PharmacoL Rev. (2002) 54:375–429.
  • MOUKARBEL GV, AYOUB CM, ABCHEE AB: Pharmacological therapy for myocardial reperfusion injury. Curr. Opin. Cardiol. (2003) 4:147–153.
  • SCARABELLI TM, GOTTLIEB RA: Functional and clinical repercussions of myocyte apoptosis in the multifaceted damage by ischemia/reperfusion injury: old and new concepts after 10 years of contributions. Cell Death Differ. (2004) 11:S144–152.
  • FISCHER S: Inhibition of angiotensin-converting enzyme by captopril: a novel approach to reduce ischemia-reperfusion injury after lung transplantation. Cardiovasc. Surg. (2000) 120:573–580.
  • GOTTMAN U, VAN DER WOUDE FJ, BRAUN C: Endothelin receptor antagonists: a new therapeutic option for improving the outcome after solid organ transplantation? Curr. Vasc. Pharmacol. (2003) 1:281–299.
  • RITTER T, KUPIEC-WEGLINSKI JW: Gene therapy for the prevention of ischaemia/reperfusion injury in organ transplantation. Curr. Gene Thera)). (2005) 5:101–109.
  • KIM Y-S, DORE S: Catalytically inactive heme oxygenase-2 mutant is cytoprotective. Free Rad. Biol. Med. (2005) 39:558–564.
  • DERNEK S, IKIZLER M, UYGUC 0 et al.: The effectiveness of ischemic preconditioning on myocardial protection and comparison with IQ- cardioplegia. Cardiovasc. Surg. (2000) 8:466–473.
  • SIGG DC, COLES JA, OELTGEN PR et al.: Role of 8-opioid receptor agonists on infarct size reduction in swine. Am. J. PhysioL Heart Circ. PhysioL (2002) 282:H1953–H1960.
  • SINDRAM D, RD-DIGER HA, UPADHYA AG et al.: Ischemic preconditioning protects against cold ischemic injury through an oxidative stress dependent mechanism. J. HepatoL (2002) 36:78–84.
  • PERALTA C, SERAFN A, FERNANDEZ -ZABALEGUI Let at.: Liver ischemic preconditioning: a new strategy for the prevention of ischemia-reperfusion injury. TranspL Proceed. (2003) 35:1800–1802.
  • ERSPAMER V, MELCHIORRI P, FALCONIERI-ERSPAMER G: Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for 8 opioid binding sites. Proc. Nail. Acad. Sci. USA (1989) 86:5188–5192:
  • OTTANI A, VERGONI AV, SALTINI S et al.: Effect of late treatment with y-hydroxybutyrate on the histological and behavioural consequences of transient brain ischemia in the rat. Eur. J. Pharmacol. (2004) 485:183–191.
  • WEI ZZ, XIA SS: y-Hyciroxybutyrate protects the liver from warm ischemia-reperfusion injury in the rat. Hepatobihary Pancreat. Dis. Int. (2004) 3:245–249.
  • TEOH LK, GRANT R, HULF JA et al.: A comparison between ischaemic preconditioning, intermittent cross-clamp fibrillation and cold crystalloid cardioplegia for myocardial protection during coronary artery bypass graft surgery. Cardiovasc. Surg. (2002) 10:251–255.
  • DOBSON GP: Organ arrest, protection and preservation: natural hibernation to cardiac surgery. Comp. Biochem. Physiol. (2004) 139:469–485.
  • DE HERT SG, TURANI F, MATHUR S et al.: Cardioprotection with volatile anesthetics: mechanisms and clinical implications. Anesth. Analg. (2005) 100:1584–1593.
  • LINDELL SL, KLAHN SL, PIAZZA TM et al.: Natural resistance to liver cold ischemia-reperfusion injury associated with the hibernation phenotype. Am. J. PhysioL Gastrointest Liver PhysioL (2005) 288:G473–G480.
  • KRENZ M, COHEN MV, DOWNEY JM: The protective and anti-protective effects of ethanol in a myocardial infarct model. Ann. NY Acad. Sci. (2002) 957:103–114.
  • LUCAS DL, BROWN RA, WASSEF M et al.: Alcohol and the cardiovascular system. J. Am. Coll. CardioL (2005) 45:1916–1924.
  • FRANCIS TJ, GOLDEN F ST C: Non-freezing cold injury: the pathogenesis. J. Roy. Nan Med. Serv. (1985) 71:3–8.
  • THOMAS JR, SHURTLEFF D, SCHROT J et al.: Cold-induced perturbation of cutaneous blood flow in the rat model of non-freezing cold injury. Microvasc. Res. (194) 47:166–176.
  • IRWIN MS: Nature and mechanism of peripheral nerve damage in an experimental model of non-freezing cold injury. Ann. R. Coll. Surg-. Engl. (1996) 78:372–379.
  • IRWIN MS: Neuropathy in non-freezing cold injury (trench foot). J. R. Soc. Med. (1997) 90:433–438.
  • LONG WB III, EDLICH RF, WINTERS KL et al.: Cold injuries. J. Long Term Eft: Med. Implants (2004) 15:67–78.
  • ENDRICH B, HAMMERSEN F, MEBMER K: Microvascular ultrastructure in non-freezing cold injuries. Res. Exp. Med. (1990) 190:365–379.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.